Fluorescein Sodium And Benoxinate Hydrochloride Drug Interactions
Fluorescein Sodium And Benoxinate Hydrochloride Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Fluorescein Sodium And Benoxinate Hydrochloride. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The risk or severity of methemoglobinemia can be increased when Abemaciclib is combined with Oxybuprocaine.
Level 1 evidence
Abiraterone
The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Oxybuprocaine.
Level 1 evidence
Acetaminophen
The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Oxybuprocaine.
Level 1 evidence
Acetazolamide
The risk or severity of methemoglobinemia can be increased when Acetazolamide is combined with Oxybuprocaine.
Level 1 evidence
Acetic acid
The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Oxybuprocaine.
Level 1 evidence
Acetyl sulfisoxazole
The risk or severity of methemoglobinemia can be increased when Acetyl sulfisoxazole is combined with Oxybuprocaine.
Level 1 evidence
Acetylsalicylic acid
The excretion of Fluorescein can be decreased when combined with Acetylsalicylic acid.
Level 2 evidence
Acyclovir
The excretion of Fluorescein can be decreased when combined with Acyclovir.
Level 2 evidence
Adagrasib
The risk or severity of methemoglobinemia can be increased when Adagrasib is combined with Oxybuprocaine.
Level 1 evidence
Afatinib
The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Oxybuprocaine.
Level 1 evidence
Aldesleukin
The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Oxybuprocaine.
Level 1 evidence
Alectinib
The risk or severity of methemoglobinemia can be increased when Alectinib is combined with Oxybuprocaine.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Fluorescein Sodium And Benoxinate Hydrochloride
Fluorescein Sodium And Benoxinate Hydrochloride has 897 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Fluorescein Sodium And Benoxinate Hydrochloride has 8 major, 832 moderate, and 57 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Fluorescein Sodium And Benoxinate Hydrochloride. Always confirm against the full prescribing information.